iRhythm Holdings, Inc. filed a Form 8-K on September 22, 2026, disclosing that the Hart-Scott-Rodino antitrust waiting period for its planned acquisition of Vital Connect, Inc. expired on September 18, 2026, with the deal anticipated to close in early October 2026.
Key Highlights
- HSR waiting period expired: The waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 expired at 11:59 p.m. Eastern Time on September 18, 2026.
- Merger agreement date: The Agreement and Plan of Merger was entered into on August 5, 2026, according to the filing.
- Target company: Vital Connect, Inc., a Delaware corporation, is the acquisition target.
- Acquirer structure: iRhythm Technologies, Inc. is the direct acquiring subsidiary, with Merger Sub merging into Vital Connect, leaving Vital Connect as a wholly owned subsidiary of iRhythm Technologies and an indirect wholly owned subsidiary of iRhythm Holdings.
- Anticipated closing: The filing states the acquisition is "currently anticipated to close in early October 2026, subject to the satisfaction or waiver of customary closing conditions."
- Stockholder representative: Fortis Advisors LLC is acting solely as representative of the Target's stockholders under the merger agreement.
iRhythm Holdings Clears Antitrust Review in Vital Connect Acquisition
According to the filing, iRhythm Holdings, Inc. (NASDAQ:IRTC) disclosed under Item 7.01 (Regulation FD Disclosure) that a key regulatory milestone has been reached in its proposed acquisition of Vital Connect, Inc. The Hart-Scott-Rodino antitrust waiting period, which must lapse before certain mergers can proceed, expired at 11:59 p.m. Eastern Time on September 18, 2026, the filing states.
The merger agreement, dated August 5, 2026, involves iRhythm Holdings as the parent company, its wholly owned subsidiary iRhythm Technologies, Inc. as the direct acquirer, and a newly formed entity, Project Vessel Merger Sub, Inc., as the merger vehicle. Under the terms described in the filing, Merger Sub will merge with and into Vital Connect, with Vital Connect surviving as a direct wholly owned subsidiary of iRhythm Technologies and an indirect wholly owned subsidiary of iRhythm Holdings. Fortis Advisors LLC is party to the agreement solely in its capacity as representative of the Target's stockholders.
The filing notes that the acquisition is anticipated to close in early October 2026, contingent on the satisfaction or waiver of customary closing conditions. The filing was signed by Daniel Wilson, Chief Financial Officer of iRhythm Holdings, Inc. The company also noted that forward-looking statements in the filing, including those regarding the expected timing and completion of the acquisition, involve risks and uncertainties and are subject to the cautionary language described in the filing.
What Was Disclosed
iRhythm Holdings reported the expiration of the HSR antitrust waiting period on September 18, 2026, related to its planned acquisition of Vital Connect, Inc., with closing anticipated in early October 2026, subject to customary conditions.



Please wait processing your request...